Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

Skin Disease Clinical Trial

— Telemalrares  

Official title:

Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02465476
• Other study ID #: RC31/13/6901
• Status: Completed
• Phase: N/A
• Start date: January 6, 2015
• Est. completion date: May 30, 2018

Study information

• Verified date: November 2018
• Source: University Hospital, Toulouse
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators want to demonstrate that a new organization with telemedicine could rationalize the treatment pathway of patient suffering from rare skin disease. A diagnosis and a personalised treatment pathway could be performed before the consultation in the hospital.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 212
• Est. completion date: May 30, 2018
• Est. primary completion date: May 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• New patients suffering from a rare skin disease whatever pathology or age, which needs a take-over by this centre

• Or patients already take-over by the centre but lost to follow-up for more than one year

• Patients (and/or parents) who give their consents

• Patients (and/or parents) able to fill in questionnaires

Exclusion Criteria:

• Pregnant or breast-feeding women.

• Patients subject to a judicial safeguard order

• Patients who need an emergency take-over

• Patients followed by a doctor who does not have a computerized system or refuse to send data via the secured messaging

Related Conditions & MeSH terms

• Skin Disease
• Skin Diseases

Intervention

Procedure:
• telemedicine
treatment pathway organized by telemedicine

Locations

Country	Name	City	State
France	UHToulouse	Toulouse

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of hospital visits	Interest of a procedure of telemedicine on the organization of the treatment pathway of patients affected by rare skin diseases in terms of change of the number of visit in hospital.	6 months
Secondary	Improvement of the treatment pathway and its organization	Traceability in the information system by composite criteria : number of completed application forms, number of meeting per month, number of meeting a month, number of patients treated a month, time dedicated to the logistical coordination (collection by sheets of weekly time) and number of new patients per month.	6 months
Secondary	Satisfaction of the patient	questionnaire of satisfaction Short Form-36 Health Survey (SF36)	6 months
Secondary	Change of the cost related to the patient care (direct and indirect).	Composite criteria with number of consultations and hospitalizations, number of visit in hospital and number of days of work and school absenteeism.	6 months
Secondary	management of time by the medical personal.	collection by sheets of weekly time	6 months